Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands at the forefront of the biotechnology sector, focusing on the development of novel therapeutics for rare diseases. With a market capitalization of $2.73 billion,..
Atrium Therapeutics, Inc. (NASDAQ: RNA), a promising player in the biotechnology sector, is capturing investor attention with a striking 86.15% potential upside, according to analyst ratings. This San Diego-based biopharmaceutical..
Molina Healthcare Inc (MOH), a stalwart in the healthcare plans industry, is a significant player in the U.S. healthcare market, providing managed healthcare services to low-income families and individuals. Operating..
As an integral player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) operates in the diagnostics and research industry, providing transformative solutions that convert biological samples into molecular insights. Headquartered..
HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity within the healthcare sector, specifically in the medical care facilities industry. With its headquarters nestled in Nashville, Tennessee, HCA Healthcare..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its focus on developing innovative therapies for central nervous system (CNS) disorders. With a market capitalization of..
Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with a potential upside of 25.52%. This potential growth is highlighted..
Revolution Medicines, Inc. (NASDAQ: RVMD) is a formidable player in the biotechnology sector, with a focus on precision oncology. Specializing in developing targeted therapies for RAS-addicted cancers, the company is..
HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare information services industry, is grabbing the attention of savvy investors with its significant growth potential and robust market positioning. With..
Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its potential upside of 33.40%, as indicated by its average target price of $44.53. This Ireland-based biopharmaceutical company operates in the..
Investors with an eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an enticing opportunity. With a market capitalization of $365.43 billion, this U.S.-based biopharmaceutical giant remains a..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising advancements in treating rare neuroendocrine diseases. With a current market capitalization of $5.61 billion, Rhythm..
For investors with a keen interest in the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing prospect. With a market capitalization of $5.52 billion, this Redwood City, California-based..
ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, operates within the biotechnology industry, specializing in the development and commercialization of plasma-derived biologics. Headquartered in Ramsey, New..
AstraZeneca PLC (AZN), a leading player in the biopharmaceutical sector, continues to capture investor attention with its robust market presence and a significant potential upside. This UK-based healthcare giant, with..
Cardinal Health, Inc. (NYSE: CAH) is a heavyweight in the healthcare sector, specializing in medical distribution—a critical industry that ensures the smooth delivery of healthcare products across the United States..
Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With a market..
Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, continues to attract attention with its innovative patient monitoring technologies. Headquartered in Irvine, California, Masimo has carved a..
UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector with a substantial market capitalization of $334.93 billion, remains a formidable player in the healthcare plans industry. With its..
